CVE:HIV

HIVE Blockchain Technologies (HIV) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HIV stock logo

About HIVE Blockchain Technologies Stock (CVE:HIV)

HIV Stock News Headlines

Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
HIVE Apr 2024 1.000 call
Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
See More Headlines
Receive HIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HIVE Blockchain Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/12/2024
Today
4/26/2024
Next Earnings (Estimated)
7/04/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
CIK
N/A
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

HIV Stock Analysis - Frequently Asked Questions

Should I buy or sell HIVE Blockchain Technologies stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HIVE Blockchain Technologies in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" HIV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HIV, but not buy additional shares or sell existing shares.
View HIV analyst ratings
or view top-rated stocks.

When is HIVE Blockchain Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 4th 2024.
View our HIV earnings forecast
.

How were HIVE Blockchain Technologies' earnings last quarter?

HIVE Blockchain Technologies Ltd. (CVE:HIV) issued its earnings results on Monday, February, 12th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.16) by $0.05. The business earned $42.55 million during the quarter, compared to analyst estimates of $32.35 million.

How do I buy shares of HIVE Blockchain Technologies?

Shares of HIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:HIV) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners